2026 Agenda – coming soon

Modern technology transfer is much more than just submitting documentation and completing registration/validation runs.

It’s a process of managing knowledge, risk, and change throughout the product lifecycle.

During the presentation, I will present a practical perspective on technology transfer from the perspective of development, production, and MS&T organization, demonstrating how to build a lasting bridge between innovation and efficient manufacturing.

Participants will learn proven approaches to increase implementation effectiveness and mitigate risk during the commercialization phase.

Sustainability in pharma today means much more than just communication in an ESG report. It encompasses specific decisions regarding excipient selection, raw material sources, formulation stability, carbon footprint (CFP), and supply security. During the presentation, Croda Pharma will demonstrate how advanced raw material research, CFP data, and a portfolio of highly purified excipients help drug manufacturers create products more responsibly and sustainably. This presentation is for companies seeking to translate environmental goals into practical actions in pharmaceutical development and production.

Is QA’s role solely to enforce compliance? During this presentation, we will discuss how to balance quality, GMP requirements, and business and operational needs in practice. Using examples from daily work related to deviations, complaints, and production issues, we will discuss risk assessment, decision-making, and building a collaborative partnership between QA and production.

This presentation is for anyone who wants to view QA as a business-supporting partner, not just a control function.

What makes Production and Maintenance a cohesive team that effectively protects supply continuity? True strength lies in consistent communication and fully utilizing the potential of the production floor – where the operator’s keen senses and expertise allow them to detect the first signs of anomalies before they impact the schedule. From the perspective of a production management practitioner, I will show you how to break down interdepartmental silos and turn everyday technical challenges into shared wins for the entire plant.

In pharmaceutical maintenance, any unplanned OT network failure poses a risk of line downtime and delivery delays, and any change to a validated system requires change control – two regimes that, in practice, work against each other. During my presentation, I will demonstrate how rapid first-contact diagnostics and properly designed OT network security shorten the duration of outages without compromising production continuity or GMP compliance. Participants will learn how to passively monitor industrial networks – without interfering with PLCs and risking validation – and where gaps most often arise when packaging lines with serialization integrate with MES and ERP systems. This is all tied together by KSC 2.0: after the October self-identification of key entities, plants are entering the phase of actual ISMS implementation (deadline: April 2027) and preparations for the first audit – and the security and continuity of the OT network are becoming not only an operational issue but a responsibility with the management board’s personal responsibility.

The Model Line is more than just a production process improvement initiative. It’s an environment where problems are identified, analyzed, and permanently resolved, not merely corrected with temporary measures. During the presentation, we’ll demonstrate how employee engagement, the use of data, and a structured approach to problem-solving can systematically improve efficiency, quality, and process stability.

The presentation aims to demonstrate the pharmaceutical label not as a simple information carrier, but as a crucial element of patient safety and the entire medicinal product distribution chain.

The presentation will cover the most important challenges related to pharmaceutical labeling, from limited packaging space, multilingualism, and version management, through serialization and tamper evidence, to the digitization of product information and sustainable packaging design.

Particular attention will be paid to the quality and functionality of labels in real-world processes: code readability, visual inspection, product traceability, and the consequences of even seemingly minor errors.

The main thesis: the future of pharmaceutical labeling lies in the combination of safety, regulatory compliance, print quality, and data quality, because ultimately, labels should not only inform but, above all, help protect patients.

This presentation examines the implementation of centralized recipe management and material handling in a Softgel production facility comprising eight production vessels. Using a real-world project as a case study, it explores how recipes and material flows are coordinated across multiple production units while maintaining operational flexibility and continuity. Attendees will gain practical insights into the system architecture, centralized recipe control, material handling integration, and key considerations for multi-unit production in a regulated GMP manufacturing environment.

During the presentation, we will demonstrate how the TeamViewer Frontline AR (Augmented Reality) solution at TEVA Kraków supports the digital transformation of production, quality, and technical processes in the pharmaceutical environment.

We will present applications of augmented reality technology based on three key pillars:

Compliance and EBR (Electronic Batch Report) – support for cleanliness control and the preparation and changeover of packaging lines using AR Workflows.

The solution guides operators step-by-step through procedurally required activities while enabling the automatic creation of electronic process documentation.

Remote Expert Support (xAssist) – faster diagnosis and resolution of technical issues thanks to live AR video connections.

Experts and Specialists can provide remote support to operators using visual cues, annotations, and instructions displayed directly in the user’s field of view.

Employee Onboarding and Skill Development – ​​effective onboarding of new operators and standardization of tasks through interactive, step-by-step instructions, reducing the risk of errors and shortening training time. We invite you to a presentation of AR applications that increase process compliance, operational efficiency, and work quality and safety.

Which solutions actually improve production efficiency, quality, and safety, and which remain merely attractive concepts? During the debate, industry representatives will discuss automation, data integration, production systems, and technologies that support decision-making in the realities of a regulated pharmaceutical facility.

This discussion focuses on specific implementations, measurable outcomes, and the barriers that determine the success of digital transformation.

Are traditional supplements no longer enough? The future of supplementation won’t start tomorrow—it’s happening today! Welcome to the World of Supplementation 2.0—a place where breakthrough technologies, advanced delivery methods, and solutions that enhance bioavailability are setting new standards for effectiveness, safety, and quality. It’s here and now that a new dimension of supplementation is emerging, redefining how the industry responds to the growing expectations of informed consumers, manufacturers, and product development specialists.

The food supplement industry offers new ingredients and products described as “groundbreaking” almost every day. Which of them truly stand out from a scientific and technological perspective?

Does every branded raw material add value? Can every scientific publication be treated as indisputable evidence?

The presentation will focus on unsubstantiated promises, interpretation errors and the pitfalls that teams responsible for new product development may encounter.

The implementation of a food supplement containing an innovative ingredient of natural origin is a process that requires much more than confirming its efficacy in scientific studies. A comprehensive assessment of the ingredient in terms of quality, compliance with regulatory requirements and the technological feasibility of its application is of key importance.

During the presentation, the most important stages of assessing innovative ingredients of natural origin will be presented – from the characterisation of the raw material and analysis of the available scientific data, through the assessment of compliance with applicable regulations and compatibility with the product formulation, to aspects related to the production process and market launch.

The presentation will have a practical character and will show which criteria should be taken into account when selecting innovative ingredients of natural origin in order to increase the chances of developing a safe, stable and reproducible food supplement that meets quality, regulatory and technological requirements and responds to market expectations.

Active and smart packaging represent one of the new trends in packaging development. Active packaging helps to extend a product’s shelf life, whilst smart packaging provides information on the product’s condition or storage conditions. Some solutions, such as moisture absorbers, which are a type of active packaging, have been known and used for a very long time, but new solutions are being proposed, particularly in the field of smart packaging.

The efficiency of a collaboration with a contract manufacturer is often determined even before the project begins – during the project preparation phase.

During this presentation, I will demonstrate the development of a new project through the manufacturer’s eyes: what information in the project request can actually shorten implementation time, and which decisions should be made before the quotation begins.

I will discuss typical trouble spots – from establishing product specifications to volatile raw material prices – and where avoidable delays most often occur. I will also suggest questions to ask yourself and the manufacturer before the project begins.

The most valuable resource in R&D is the time of experienced experts. The presentation will show how digitalization, AI, LLMs and automation can shorten the path from brief to production, structure knowledge and reduce manual work.

The starting point will be solutions already implemented in practice: digital support for formulation and regulatory compliance, packaging and PPWR data, the electronic Batch Report, and a paperless laboratory. The key question is: where does R&D lose time, money and knowledge, and how can technology help recover them?

During the presentation, I will show how modern quality control systems can reduce the risk of errors at the final stages of cosmetics production and packaging. Using examples of solutions based on in-line inspection, AI-powered vision systems and process traceability, I will demonstrate how non-conformities can be detected automatically before the product leaves the production line. I will also explain how such solutions help manufacturers maintain consistent quality and ensure product compliance with defined requirements.

Behind a seemingly simple package lies an entire ecosystem of decisions – from design and technology to production, costs, regulations and consumer expectations. Packaging is no longer merely an addition to the product; it has become part of the brand strategy. When designed well, it not only protects and differentiates the product, but also builds value, optimizes processes and prepares the brand for the future.